Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

NCT03362879 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03362879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03362879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COSMOS - COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 14, 2017
Completion date
December 17, 2018
Enrollment
412 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)